Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 6/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5609343 | 0.91 | RXRA (0.31) | — | |
| SCHEMBL5614987 | 0.90 | TACR1 (0.31) | TACR1CNR1CNR2BACE1 | |
| SCHEMBL5609422 | 0.89 | TACR1 (0.32) | TACR1CNR1CNR2 | |
| SCHEMBL5610575 | 0.88 | TACR1 (0.32) | TACR1 | |
| SCHEMBL5614749 | 0.87 | AKR1C3 (0.31) | — | |
| SCHEMBL5609684 | 0.87 | — | — | |
| SCHEMBL5609300 | 0.86 | TACR1 (0.31) | TACR1 | |
| SCHEMBL5609221 | 0.86 | IKBKB (0.33) | — | |
| SCHEMBL5609469 | 0.86 | — | — | |
| SCHEMBL5614862 | 0.85 | TACR1 (0.31) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1640377-B1 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIL CHEM PATENTS INC (US) | 2007-07-25 | — | — | EP | disclosed |
| US-7157591-B2 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIE CHEMICAL PATENTS INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-20050037919-A1 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037919-A1 | Metallocenes and catalyst compositions derived therefrom | HMOX1, RTF1, OPRM1 | TACR1 2616/4885ACLY 2273/4885CNR1 2611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.